| 000 | 01743 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515184504.0 | ||
| 264 | 0 | _c20100108 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1573-7292 | ||
| 024 | 7 |
_a10.1007/s10689-009-9288-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoyner, David E | |
| 245 | 0 | 0 |
_aFAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin. _h[electronic resource] |
| 260 |
_bFamilial cancer _c2009 |
||
| 300 |
_a569-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenomatous Polyposis Coli _xcomplications |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aDesmoid Tumors _xgenetics |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 1 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xgenetics |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 700 | 1 | _aTrang, Sylvia H | |
| 700 | 1 | _aAboulafia, Albert J | |
| 700 | 1 | _aDamron, Timothy A | |
| 700 | 1 | _aRandall, R L | |
| 700 | 1 | _aRandall, R Lor | |
| 773 | 0 |
_tFamilial cancer _gvol. 8 _gno. 4 _gp. 569-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10689-009-9288-y _zAvailable from publisher's website |
| 999 |
_c19128646 _d19128646 |
||